- Oil execs work COP29 as NGOs slam lobbyist presence
- Gore says climate progress 'won't slow much' because of Trump
- 'Megaquake' warning hits Japan's growth
- Stiff business: Berlin startup will freeze your corpse for monthly fee
- Wars, looming Trump reign set to dominate G20 summit
- Xi, Biden attend Asia-Pacific summit, prepare to meet
- Kyrgios to make competitive return at Brisbane next month after injuries
- Dominican Juan Luis Guerra triumphs at 25th annual Latin Grammys
- Landslide win for Sri Lanka president's leftist coalition in snap polls
- Australian World Cup penalty hero Vine takes mental health break
- As Philippines picks up from Usagi, a fresh storm bears down
- Tropical Storm Sara pounds Honduras with heavy rain
- Pepi gives Pochettino win for USA in Jamaica
- 'Hell to heaven' as China reignite World Cup hopes with late winner
- Rebel attacks keep Indian-run Kashmir on the boil
- New Zealand challenge 'immense but fantastic' for France
- Under pressure England boss Borthwick in Springboks' spotlight
- All Blacks plan to nullify 'freakish' Dupont, says Lienert-Brown
- TikTok makes AI driven ad tool available globally
- Japan growth slows as new PM readies stimulus
- China retail sales pick up speed, beat forecasts in October
- Asian markets fluctuate at end of tough week
- Gay, trans people voicing -- and sometimes screaming -- Trump concerns
- Argentina fall in Paraguay, Brazil held in Venezuela
- N. Korean leader orders 'mass production' of attack drones
- Pakistan's policies hazy as it fights smog
- Nature pays price for war in Israel's north
- New Zealand's prolific Williamson back for England Test series
- Mexico City youth grapple with growing housing crisis
- After Trump's victory, US election falsehoods shift left
- Cracks deepen in Canada's pro-immigration 'consensus'
- Xi inaugurates South America's first Chinese-funded port in Peru
- Tyson slaps Paul in final face-off before Netflix bout
- England wrap-up T20 series win over West Indies
- Stewards intervene to stop Israel, France football fans clash at Paris match
- Special counsel hits pause on Trump documents case
- Japan's Princess Mikasa, great aunt to emperor, dies aged 101
- Cricket at 2028 Olympics could be held outside Los Angeles
- Trump names vaccine skeptic RFK Jr. to head health dept
- Ye claims 'Jews' controlling Kardashian clan: lawsuit
- Japan into BJK Cup quarter-finals as Slovakia stun USA
- Sri Lanka president's party headed for landslide: early results
- Olympics 'above politics' say LA 2028 organisers after Trump win
- Panic strikes Port-au-Prince as residents flee gang violence
- Carsley hails England's strength in depth as understudies sink Greece
- Undefeated Chiefs lose kicker Butker to knee injury
- Wallabies winger Vunivalu signs for La Rochelle
- Musk met Iran UN ambassador on defusing tension under Trump: NYT
- Vinicius misses penalty as Brazil held in Venezuela
- World's tallest teen Rioux won't make college debut until 2025
RBGPF | 100% | 61.84 | $ | |
RELX | -0.37% | 45.95 | $ | |
SCS | -0.75% | 13.27 | $ | |
RIO | -0.31% | 60.43 | $ | |
RYCEF | -4.71% | 6.79 | $ | |
GSK | -2.09% | 34.39 | $ | |
CMSD | -0.02% | 24.725 | $ | |
CMSC | -0.24% | 24.55 | $ | |
NGG | 0.4% | 62.37 | $ | |
VOD | -0.81% | 8.68 | $ | |
AZN | -0.38% | 65.04 | $ | |
JRI | -0.23% | 13.21 | $ | |
BCC | -1.57% | 140.35 | $ | |
BTI | 0.2% | 35.49 | $ | |
BP | 1.65% | 29.05 | $ | |
BCE | -1.38% | 26.84 | $ |
Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist -- a concept once dismissed as "crazy."
Today, proteins with novel functions are flowing steadily out of his lab, with an endless list of potential applications ranging from ultra-targeted therapies to the development of new vaccines.
"Across the range of problems that we face today in medicine and health, sustainability, energy, and technology, I think the potential for protein design is enormous," Baker told AFP via video call from Seattle, hours after learning of his Nobel win alongside two other laureates.
Proteins are organic molecules that play a fundamental role in almost every function of living organisms, from muscle contraction and food digestion to neuron activation and more.
"The ones in nature evolved to solve all the problems that were faced during natural selection," explained the 62-year-old University of Washington professor.
"But humans face new problems today," added the biochemist and computational biologist.
"We're heating up the planet, so we need new solutions in ecology and sustainability. We live longer, so there's new diseases which are relevant, like Alzheimer's disease. There's new pathogens like coronavirus."
Rather than leave these problems up to evolution -- a "brutal" solution that would take a very, very long time -- "with new proteins, we can solve those problems, but in a very short time," he said.
- From fringe to mainstream -
All proteins are composed of chains of amino acids, whose sequence dictates their shape -- and ultimately their function.
For decades, scientists have tried to determine protein structures based on these amino acid sequences.
In the late 1990s, Baker made strides towards solving this problem with a computer software he developed called Rosetta.
His success prompted a shift his focus to the reverse approach: starting with a desired shape and using Rosetta to identify the corresponding amino acid sequence. This sequence can then be introduced into bacteria, which synthesize the new protein that can be harvested and studied.
In 2003, he published his breakthrough finding -- the creation of the first-ever protein not found in nature -- though it still lacked a defined function.
"Then we started trying to design proteins that actually would do useful things," Baker recalled. "And that's when people, I think, really started thinking it was crazy."
But "for the last 20 years -— and really, most recently, the last five years -— we've been able to make proteins that do all kinds of amazing things," he said. Rosetta meanwhile has been progressively improved to incorporate artificial intelligence.
"I think what's kind of funny now is that the lunatic fringe, which pretty much no one was doing, has now entered the mainstream," he added with a laugh.
- Keys that fit locks -
How do scientists decide what shape a new protein needs to achieve the desired function?
Baker gives the example of a tumor. "We know some protein that's on the surface of that tumor, and we know its shape. What we do is we design a protein that acts like a key fitting into a lock," he explained.
Another application: breaking down plastic. In this case, a protein is designed to attach itself to the plastic molecule, accompanied by chemical compounds to "cut" it.
In medicine, this technology has already been used in a Covid-19 vaccine approved in South Korea. Researchers are also exploring its potential to create new materials.
"In biology, we have tooth and bone, we have shells, which are made by proteins interacting with inorganic compounds like calcium carbonate or calcium phosphate," says Baker, envisioning proteins interacting with other compounds to create entirely new materials with unique properties.
Greenhouse gas capture, a universal flu vaccine, improved antivenom -- Baker's wish list goes on and on.
"As protein design becomes more powerful, I'm incredibly excited about all the problems that we will be able to solve."
H.Romero--AT